Who Paid My Doc
Travis Blalock
MOHS-Micrographic Surgery Oklahoma City, OK Medical Doctor
NPI 1710195003 CMS profile 725678
619 Ne 13Th St, Oklahoma City, OK 73104
General payments
$12,879
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Travis Blalock of Oklahoma City, OK is reported in the CMS Open Payments database as having received $12,879 across 13 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 91st percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $10,829 | 11 | |
| 2023 | General | $2,030 | 1 | |
| 2021 | General | $20 | 1 |
Beside peers
- Travis Blalock
- MOHS-Micrographic Surgery median
- Middle half of MOHS-Micrographic Surgery
- National median
In program year 2025, general payments to Travis Blalock were reported at $10,829. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.
Show as a table
| Year | Travis Blalock | MOHS-Micrographic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $316 | $106–$785 | $163 |
| 2020 | $0 | $162 | $68–$412 | $114 |
| 2021 | $20 | $243 | $87–$654 | $132 |
| 2022 | $0 | $300 | $102–$887 | $149 |
| 2023 | $2,030 | $364 | $125–$1,010 | $160 |
| 2024 | $0 | $445 | $142–$1,108 | $164 |
| 2025 | $10,829 | $465 | $145–$1,066 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
334
Drug cost
$9,675
Branded share of claims
13.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Fluorouracil | Generic | 35 | $2,783 | |
| Calcipotriene | Generic | 15 | $2,282 | |
| Doxycycline Hyclate | Generic | 98 | $1,135 | |
| Gentamicin Sulfate | Generic | 22 | $1,028 | |
| Imiquimod | Generic | 19 | $728 | |
| Clobetasol Propionate | Generic | 16 | $595 | |
| Triamcinolone Acetonide | Generic | 25 | $469 | |
| Mupirocin | Generic | 35 | $283 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 18 | $142 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 26 | $104 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 103 billing codesPaid by Medicare
$323,054
Medicare patients
393
Services billed
1,346
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 69% | |
| Arthritis | 38% | |
| Ischemic heart disease | 25% | |
| Diabetes | 22% | |
| Chronic kidney disease | 21% | |
| Cancer | 18% | |
| Depression | 17% | |
| Atrial fibrillation | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Oasis wound matrix, per square centimeter Q4102 | Office | 16 | 54 | $524 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
13 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other MOHS-Micrographic Surgery in Oklahoma
Carlos Garcia
MOHS-Micrographic Surgery · Oklahoma City, OK
Robert Fischer
MOHS-Micrographic Surgery · Tulsa, OK
Carlos Gomez-Meade
MOHS-Micrographic Surgery · Broken Arrow, OK
Jason Hirshburg
MOHS-Micrographic Surgery · Oklahoma City, OK
Mary Christian Reed
MOHS-Micrographic Surgery · Tulsa, OK
Todd Mollet
MOHS-Micrographic Surgery · Oklahoma City, OK
Related records
MOHS-Micrographic Surgery in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All MOHS-Micrographic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.